Government’s new ‘shared commitments’ set out priority actions for genomics initiatives across UK
A new UK-wide shared commitments published by the regulators aim to accelerate genomic research and drive innovation in healthcare.
For the first time, the new...
Avril Chester to join RPS as Chief Technology Officer from June
The Royal Pharmaceutical Society (RPS) has appointed Avril Chester as its new Chief Technology Officer.
Avril joins the RPS in June and will be accountable...
NHS struck early access deal for Mobocertinib
A deal struck by NHS England will help eligible patients of lung cancer to access Mobocertinib within weeks.
The access comes alongside approval from the...
Daiichi Sankyo, O’Brien’s Pharmacies collaborate to provide free AF checks in North West England
Daiichi Sankyo and O’Brien’s Pharmacies Group have joined hands to offer a free Atrial Fibrillation (AF) check to over 65s in North West England....
Eight community pharmacy projects to benefit from latest BCPP funding
Community Development and Health Network (CDHN) in Northern Ireland has announced that eight applicants were selected in the latest round of Level One funding...
Licencing deals struck for cheaper Pfizer Covid pill
Thirty-five generic drug manufacturers will make a more affordable version of Pfizer's anti-Covid pill for the world's poorer nations, in licensing deals announced Thursday...
RPS not to renew FIP membership
The Royal Pharmaceutical Society (RPS) has announced its decision to leave the International Pharmaceutical Federation (FIP), the global body representing pharmacy, pharmaceutical sciences and...
Life-extending injection for blood cancer accessible at NHS England
The NHS chief executive has announced that the life-extending injection 'daratumumab' for a fatal form of blood cancer will be available to around 350...
AstraZeneca’s Evusheld gets MHRA approval to treat Covid-19 patients
A new medicine, Evusheld (tixagevimab/cilgavimab), has been authorised for Covid-19 prevention after meeting the UK regulatory standards of safety, quality and effectiveness. The Medicines...
‘Pharmacists on Covid-19 temporary register will not be able to practice in NI post end of September’
Pharmacists who remain on the Covid-19 Temporary Register and do not apply to join the Register will not be able to practice in Northern...
Current Issue March 2024
